Skip to main content

Table 2 Correlation coefficient of biomarkers and EZH2 scores

From: Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions

 

EZH2

r

P-value

Primary ER status

Primary

−0.103

0.318

Primary PR status

Primary

−0.111

0.282

Primary HER2 status

Primary

0.361

<0.001*

Primary Ki-67 expression

Primary

0.722

<0.0001*

Metastatic ER status

Metastatic

−0.099

0.339

Metastatic PR status

Metastatic

−0.190

0.064

Metastatic HER2 status

Metastatic

0.306

0.002*

Metastatic Ki-67 expression

Metastatic

0.685

<0.0001*

  1. Abbreviations: ER estrogen receptor, EZH2 enhancer of zeste homolog 2, HER2 human epidermal growth factor receptor 2, PR progesterone receptor
  2. *Indicates values that are statistically significant (P < 0.01)
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us